These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2018818)

  • 21. Withdrawal symptoms after long-term treatment with flurazepam.
    Pearlman T
    Am J Psychiatry; 1984 Jan; 141(1):138-9. PubMed ID: 6691434
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: A randomized, double-blind, placebo-controlled study.
    Esaki Y; Kitajima T; Takeuchi I; Tsuboi S; Furukawa O; Moriwaki M; Fujita K; Iwata N
    Chronobiol Int; 2017; 34(6):753-761. PubMed ID: 28488943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sleep restriction for the inpatient treatment of insomnia.
    Morin CM; Kowatch RA; O'Shanick G
    Sleep; 1990 Apr; 13(2):183-6. PubMed ID: 2330476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzodiazepine dependence.
    Khong E; Sim MG; Hulse G
    Aust Fam Physician; 2004 Nov; 33(11):923-6. PubMed ID: 15584332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Withdrawal syndrome in a depressed patient treated with trazodone.
    Menza MA
    Am J Psychiatry; 1986 Sep; 143(9):1195. PubMed ID: 3752308
    [No Abstract]   [Full Text] [Related]  

  • 27. Clonazepam: sleep laboratory study of efficacy and withdrawal.
    Kales A; Manfredi RL; Vgontzas AN; Baldassano CF; Kostakos K; Kales JD
    J Clin Psychopharmacol; 1991 Jun; 11(3):189-93. PubMed ID: 2066457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety].
    Lôo H; Malka R; Hantouche E; Lancrenon S; Guelfi JD
    Encephale; 1991; 17(4):295-300. PubMed ID: 1959498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypes of sleeplessness: stressing the need for psychodiagnostics in the assessment of insomnia.
    van de Laar M; Leufkens T; Bakker B; Pevernagie D; Overeem S
    Psychol Health Med; 2017 Sep; 22(8):902-910. PubMed ID: 28133972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triazolam treatment of insomnia in depressed patients taking tricyclics.
    Cohn JB
    J Clin Psychiatry; 1983 Nov; 44(11):401-6. PubMed ID: 6139364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insomnia and sleep duration in a large cohort of patients with major depressive disorder and anxiety disorders.
    van Mill JG; Hoogendijk WJ; Vogelzangs N; van Dyck R; Penninx BW
    J Clin Psychiatry; 2010 Mar; 71(3):239-46. PubMed ID: 20331928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.
    Chakos M; Patel JK; Rosenheck R; Glick ID; Hammer MB; Tapp A; Miller A; Miller D
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):124-34. PubMed ID: 21983496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acupuncture for residual insomnia associated with major depressive disorder: a placebo- and sham-controlled, subject- and assessor-blind, randomized trial.
    Chung KF; Yeung WF; Yu YM; Yung KP; Zhang SP; Zhang ZJ; Wong MT; Lee WK; Chan LW
    J Clin Psychiatry; 2015 Jun; 76(6):e752-60. PubMed ID: 26132682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estazolam treatment of insomnia in generalized anxiety disorder: a placebo-controlled study.
    Post GL; Patrick RO; Crowder JE; Houston J; Ferguson JM; Bielski RJ; Bailey L; Pearlman HG; Shu VS; Pierce MW
    J Clin Psychopharmacol; 1991 Aug; 11(4):249-53. PubMed ID: 1918423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
    Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand MH; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
    Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the efficacy of pivagabine on insomnia associated with mood disorders.
    Negri L
    Arzneimittelforschung; 1997 Nov; 47(11A):1322-5. PubMed ID: 9450157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insomnia Symptoms Following Treatment for Comorbid Panic Disorder With Agoraphobia and Generalized Anxiety Disorder.
    Cousineau H; Marchand A; Bouchard S; Bélanger C; Gosselin P; Langlois F; Labrecque J; Dugas MJ; Belleville G
    J Nerv Ment Dis; 2016 Apr; 204(4):267-73. PubMed ID: 27019339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
    Kiev A
    J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
    Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
    J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.